Results 111 to 120 of about 429,043 (216)
Janus Kinase Inhibitor Use Among People With Inflammatory Disease in Australia
ABSTRACT Aim To describe Australian trends in JAKi uptake, where there are no restrictions on the sequence of their use in clinical practice. Methods We included all people aged 18 years and over initiating a JAKi between 1 October 2015 and 31 August 2022.
Claire T. Deakin +6 more
wiley +1 more source
Spondyloarthritis is a group of chronic inflammatory diseases that includes axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA). AxSpA primarily affects the axial skeleton, manifesting with hallmark features such as inflammatory back pain and a
Murat Torgutalp +2 more
doaj +1 more source
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease with variable clinical presentation and often delayed diagnosis. The Assessment of Spondyloarthritis International Society (ASAS) recently proposed a consensus definition of early axSpA to
Tae-Jong Kim, Sofia Ramiro
doaj +1 more source
Selection Bias in Hybrid Randomized Controlled Trials Using External Controls: A Simulation Study
ABSTRACT Hybrid randomized controlled trials (hybrid RCTs) integrate external control data, such as historical or concurrent data, with data from randomized trials. While numerous frequentist and Bayesian methods, such as the test‐then‐pool and the meta‐analytic‐predictive prior, have been developed to account for potential disagreement between the ...
Han Chang Chiam +2 more
wiley +1 more source
Abdullah Elhosiny,1 Renad Alshoubaki,1 Lama Sindi,2 Sadeem Bukhari,2 Hani Almoallim1,2 1Department of Medicine, Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia; 2Department of Medicine, Faculty of Medicine, Umm Alqura University, Makkah, Saudi ...
Elhosiny A +4 more
doaj
Anumigilimab, a novel anti‐G‐CSF receptor antibody, was investigated in a phase 1b trial involving 39 patients with hidradenitis suppurativa or palmoplantar pustulosis. No serious safety concerns related to anumigilimab were noted, and PK and PD were dose dependent.
Johannes S. Kern +14 more
wiley +1 more source
The genetics of ankylosing spondylitis and axial spondyloarthritis
Ankylosing spondylitis (AS) and spondyloarthritis are strongly genetically determined. The long-standing association with HLA-B27 is well described, although the mechanism by which that association induces AS remains uncertain.
Robinson, P. C. +3 more
core +1 more source
Epidemiology of axial spondyloarthritis
Axial spondyloarthritis (axSpA) is an inflammatory arthritis of the sacroiliac joints and spine. The prototype is ankylosing spondylitis, the radiographic form of the disease; however, more recently, an earlier or less-differentiated presentation has ...
Liron Caplan +2 more
core +1 more source
Difficult-to-Manage Axial Spondyloarthritis
Axial spondyloarthritis (axSpA) is a multifaceted disease with a wide range of manifestations and associated comorbidities. Despite an expanding arsenal of disease-modifying anti-rheumatic drugs (DMARDs) in the treatment landscape of axSpA, a substantial number of patients remains resistant to multiple therapeutic interventions, posing a clinical ...
Emmanouilidou, Evgenia +5 more
openaire +2 more sources
Axial spondyloarthritis (AxSpA) is a chronic inflammatory condition of the spine and sacroiliac joints, associated with a considerable functional and psychosocial burden.
Fatima Alnaimat +6 more
doaj +1 more source

